When The Wall Street Journalreported this past week that IBM is considering a sale of its Watson Health arm, the news was not entirely a surprise. The division has seen some major milestones in the decade since Watson first wowed the world with its much-hyped Growth and challenges Since then, the Watson business has grown substantially, through a series of targeted, multi-billion-dollar acquisitions: Merge Healthcare for imaging, Phytel and Explorsys for population health and Truven Health Analytics for value-based care. But there have also been some high-profile setbacks along the way. Most notably, there was the deployment at Houston's MD Anderson Cancer Center, where the cognitive computing technology was first deployed in 2013 to help oncologists mine for insights from the health system's vast troves of research and patient data, and develop new NLP-powered decision support tools.